Tarsus Pharmaceuticals (TARS) Earnings Date & Reports

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TARS is expected to report earnings to rise 239.53% to -146 cents per share on November 10

Tarsus Pharmaceuticals TARS Stock Earnings Reports

Q3'26

Est.

$-1.46

Q2'26

Missed

by $0.21

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.12

Q3'25

Beat

by $0.05

The last earnings report on August 06 showed earnings per share of -43 cents, missing the estimate of -21 cents. With 331.61K shares outstanding, the current market capitalization sits at 3.59B.

View a ticker or compare two or three

TARS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TARS